1. Home
  2. Analysis
  3. Thalidomide
  4. Adalat

Thalidomide and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Thalidomide (thalidomide) and Adalat (nifedipine). Common drug interactions include pneumonia among females and pancytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Thalidomide and Adalat. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

On Jul, 27, 2026

12 people who take Thalidomide and Adalat together, and have interactions are studied.

Thalidomide and Adalat drug interactions.

What are the common drug interactions of Thalidomide and Adalat, by gender? *:

female:

  1. Pneumonia
  2. Hypotension (abnormally low blood pressure)
  3. Loss of consciousness
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)
  6. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  7. Plasma cell myeloma (cancer that begins in plasma cells)

male:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Renal failure (kidney dysfunction)
  3. Diarrhoea
  4. Cardiac failure congestive
  5. Gingivitis (inflammation of gums)
  6. Osteonecrosis (death of bone)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Tooth extraction

What are the common drug interactions of Thalidomide and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Back pain
  8. Balance disorder
  9. Bone disorder
  10. Bone fragmentation

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 75.00%
  2. Stress And Anxiety: 5 people, 41.67%
  3. Hypertensive Encephalopathy (neurological dysfunction induced by malignant hypertension): 1 person, 8.33%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Thalidomide and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Thalidomide and Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adalat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide and nifedipine (the active ingredients of Thalidomide and Adalat, respectively), and Thalidomide and Adalat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.